Atlas Trials

A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment

Clinical trial NCT05145270 · UNKNOWN

Trial details

NCT number
NCT05145270
Sponsor
Shanghai Mental Health Center
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2019-11-30
Primary completion
2022-11-30
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.